#$%^&*AU2015210420B220170803.pdf#####H: aar Interwoven NRPortbl DCC AR 8188795_1.DOC-07/08/2015 - 162 ABSTRACT The present invention relates to antibodies that specifically bind to the human cMet receptor protein and that act as strict antagonists of hepatocyte growth factor (HGF)mediated activation of the c-Met receptor and also inhibit HGF-independent activation of the human c-Met protein.